Latest Breaking News On - First light asset management - Page 3 : comparemela.com

Truist Financial Trims Privia Health Group (NASDAQ:PRVA) Target Price to $24 00

Privia Health Group (NASDAQ:PRVA – Free Report) had its target price trimmed by Truist Financial from $28.00 to $24.00 in a report published on Wednesday, Benzinga reports. They currently have a buy rating on the stock. A number of other research firms also recently weighed in on PRVA. TD Cowen cut their price target on […]

United statesThomas bartrumDavid mountcastleStifel nicolausNews ratings for privia health group dailyPrivia health group price performanceSecurities exchange commissionNorges bankInsider transactions at privia health groupFirst light asset managementAnalyst recommendations for privia health groupNorthern trust corpPrivia health group incJefferies financial groupPrivia health groupRiverbridge partners

Dyne Therapeutics (NASDAQ:DYN) Trading Down 3 2%

Dyne Therapeutics (NASDAQ:DYN) Trading Down 3 2%
dailypolitical.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dailypolitical.com Daily Mail and Mail on Sunday newspapers.

United statesStifel nicolausPiper sandlerRichard william scalzoWildon farwellDyne therapeutics company profileMorgan stanleyDyne therapeutics incSecurities exchange commissionJanus henderson groupFirst light asset managementPricet rowe associates incDyne therapeuticsGet free reportTherapeutics stock downWilliam scalzo

Wedbush Comments on AnaptysBio, Inc s Q1 2025 Earnings (NASDAQ:ANAB)

Wedbush Comments on AnaptysBio, Inc s Q1 2025 Earnings (NASDAQ:ANAB)
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Ericj loumeauLeerink partnrsDaniel fagaStifel nicolausAnaptysbio incFirst light asset managementGreat point partnersSecurities exchange commissionJpmorgan chase coFranklin resources incEventide asset managementFree reportGet free reportLight asset managementPoint partnersAsset management

Insider Selling: Crinetics Pharmaceuticals, Inc (NASDAQ:CRNX) CEO Sells $5,307,931 20 in Stock

Insider Selling: Crinetics Pharmaceuticals, Inc (NASDAQ:CRNX) CEO Sells $5,307,931 20 in Stock
etfdailynews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from etfdailynews.com Daily Mail and Mail on Sunday newspapers.

New zealand generalNew zealandRobertw bairdRichard scott struthersVanguard group incQuarter for crinetics pharmaceuticalsNews ratings for crinetics pharmaceuticals dailyCantor fitzgeraldJennison associatesCrinetics pharmaceuticalsMorgan stanleyInstitutional trading of crinetics pharmaceuticalsFirst light asset managementCrinetics pharmaceuticals price performanceCrinetics pharmaceuticals incWellington management group

Paragon 28 (NYSE:FNA) Price Target Cut to $20 00 by Analysts at JMP Securities

Paragon 28 (NYSE:FNA) Price Target Cut to $20 00 by Analysts at JMP Securities
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

United statesAlbert dacostaPiper sandlerSecurities exchange commissionNeedham companyVanguard group incFirst light asset managementLoomis sayles coFree reportGet free reportExchange commissionFunds weigh in on paragonLight asset managementLoomis sayles